ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1997 • 1,775 citations

Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency

1996 • 1,759 citations

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1997 • 1,680 citations

Introduction to sample size determination and power analysis for clinical trials

1981 • 996 citations

Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure

1999 • 898 citations

Angiotensin-Converting Enzyme Inhibitor–Associated Elevations in Serum Creatinine

2000 • 779 citations

Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy

1996 • 427 citations

Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.

1994 • 227 citations

Randomised controlled trial of enalapril and blockers in non- diabetic chronic renal failure

1994 • 224 citations

Hyperkalemia in Outpatients Using Angiotensin-Converting Enzyme Inhibitors

1998 • 216 citations

Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.

1993 • 199 citations

Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease.

1998 • 163 citations

Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.

1993 • 133 citations

Comparative Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Antagonism on Plasma Fibrinolytic Balance in Humans

1999 • 125 citations

Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.

1994 • 111 citations

Vascular remodeling: The role of angiotensin-converting enzyme inhibitors

1998 • 97 citations

Aldosterone and potassium homeostasis

1996 • 95 citations

Aldosterone responses to hyperkalemia in healthy elderly humans.

1995 • 62 citations

The AB/BA crossover: past, present and future?

1994 • 61 citations

Blood pressure variability, cardiovascular risk and antihypertensive treatment

1995 • 51 citations

Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure.

1996 • 47 citations

University of Miami Division of Clinical Pharmacology Therapeutic Rounds

1998 • 28 citations

A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium

1999 • 26 citations

Plasma renin methodology

1995 • 23 citations

Vascular and renal prostaglandins as counter-regulatory systems in heart failure

1988 • 16 citations

Role of the Tissue Renin-Angiotensin System in the Action of Angiotensin-Converting Enzyme Inhibitors

1995 • 8 citations

Effect of High-Dose Aldosterone Infusions on Renal Electrolyte Excretion in Patients with Renal Insufficiency

1987 • 6 citations

Urinary prostaglandins (PGE<sub>2</sub> and PGI<sub>2</sub>) in hyporeninaemic hypoaldosteronism in diabetic patients with chronic renal failure

1994 • 3 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...